MedTrace Logo

Spanish Urological Association Registry of Patients on Active Surveillance

NCT02865330 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 946

Last updated 2018-02-12

No results posted yet for this study

Summary

Description:

Multicentre observational study, not randomized. Ambispective character (retro and prospective). Opened to any member of the Asociación Española de Urología (AEU), public and private medicine.

Justification:

Active surveillance is a strategy proposed to control the overtreatment derived from the opportunist screening in prostate cancer (PCa).

Its development in our country is erratic and different in every Center. This database tries to include most of patients included in active surveillance in Spain with a few minimal inclusion criteria.

Multicentre registry and follow up of the active surveillance in Spain.

Hypothesis:

Mortality cancer specific for PCa includible in active surveillance to 15 years is lower than 5 %.

Conditions

Interventions

OTHER

Registry

National Registry of patients with prostate cancer as monitored through active surveillance, with the intention of testing the hypothesis that cancer-specific mortality in very low-risk and low-risk patients is less than 5% at 15 years.

Sponsors & Collaborators

  • Fundación Instituto Valenciano de Oncología

    lead OTHER

Principal Investigators

  • Jose Rubio Briones, MD, PhD · IVO

  • Ángel Borque Fernando, MD, PhD · Hospital Miguel Servet

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-06-30
Completion
2034-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865330 on ClinicalTrials.gov